Psychological vulnerability, ventricular tachyarrhythmias and mortality in implantable cardioverter defibrillator patients: is there a link?

References

• Bardy GH, Lee KL, Mark DB et al.; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. 352(3), 225–237 (2005).
   PubMed Web of Science ®Google Scholar
• Epstein AE. Benefits of the implantable cardioverter-defibrillator. J. Am. Coll. Cardiol. 52(14), 1122–1127 (2008).
   PubMed Web of Science ®Google Scholar
• Epstein AE, DiMarco JP, Ellenbogen KA et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 51(21), e1–e62 (2008).
   PubMedGoogle Scholar
• Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann. Intern. Med. 138(6), 445–452 (2003).
   PubMed Web of Science ®Google Scholar
• Ahmad M, Bloomstein L, Roelke M, Bernstein AD, Parsonnet V. Patients’ attitudes toward implanted defibrillator shocks. Pacing Clin. Electrophysiol. 23(6), 934–938 (2000).
   PubMed Web of Science ®Google Scholar
• Carlson MD, Wilkoff BL, Maisel WH et al.; American College of Cardiology Foundation; American Heart Association; International Coalition of Pacing and Electrophysiology Organizations. Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and Electrophysiology Organizations (COPE). Heart Rhythm 3(10), 1250–1273 (2006).
   PubMed Web of Science ®Google Scholar
• Crespo EM, Kim J, Selzman KA. The use of implantable cardioverter defibrillators for the prevention of sudden cardiac death: a review of the evidence and implications. Am. J. Med. Sci. 329(5), 238–246 (2005).
   PubMed Web of Science ®Google Scholar
• Wilkoff BL, Williamson BD, Stern RS et al.; PREPARE Study Investigators. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J. Am. Coll. Cardiol. 52(7), 541–550 (2008).
   PubMed Web of Science ®Google Scholar
• Maisel WH. Safety issues involving medical devices: implications of recent implantable cardioverter-defibrillator malfunctions. JAMA 294(8), 955–958 (2005).
   PubMed Web of Science ®Google Scholar
• Jackson LR 2nd, Daubert JP, Thomas KL. Expanding the benefits of implantable cardioverter-defibrillator therapy: ‘is less more’? Prog. Cardiovasc. Dis. 54(4), 372–378 (2012).
   PubMed Web of Science ®Google Scholar
• Bardy GH, Smith WM, Hood MA et al. An entirely subcutaneous implantable cardioverter-defibrillator. N. Engl. J. Med. 363(1), 36–44 (2010).
   PubMed Web of Science ®Google Scholar
• Buxton AE. Risk stratification for sudden death in patients with coronary artery disease. Heart Rhythm 6(6), 836–847 (2009).
   PubMed Web of Science ®Google Scholar
• Amit G, Rosenbaum DS, Super DM, Costantini O. Microvolt T-wave alternans and electrophysiologic testing predict distinct arrhythmia substrates: implications for identifying patients at risk for sudden cardiac death. Heart Rhythm 7(6), 763–768 (2010).
   PubMed Web of Science ®Google Scholar
• Exner DV, Kavanagh KM, Slawnych MP et al.; REFINE Investigators. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J. Am. Coll. Cardiol. 50(24), 2275–2284 (2007).
   PubMed Web of Science ®Google Scholar
• Steinberg JS, Arshad A, Kowalski M et al. Increased incidence of life-threatening ventricular arrhythmias in implantable defibrillator patients after the World Trade Center attack. J. Am. Coll. Cardiol. 44(6), 1261–1264 (2004).
   PubMed Web of Science ®Google Scholar
• Shedd OL, Sears SF Jr, Harvill JL et al. The World Trade Center attack: increased frequency of defibrillator shocks for ventricular arrhythmias in patients living remotely from New York City. J. Am. Coll. Cardiol. 44(6), 1265–1267 (2004).
   PubMed Web of Science ®Google Scholar
• Magyar-Russell G, Thombs BD, Cai JX et al. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. J. Psychosom. Res. 71(4), 223–231 (2011).
   PubMed Web of Science ®Google Scholar
• Versteeg H, Theuns DA, Erdman RA, Jordaens L, Pedersen SS. Posttraumatic stress in implantable cardioverter defibrillator patients: the role of pre-implantation distress and shocks. Int. J. Cardiol. 146(3), 438–439 (2011).
   PubMed Web of Science ®Google Scholar
• Habibovic M, van den Broek KC, Alings M, Van der Voort PH, Denollet J. Posttraumatic stress 18 months following cardioverter defibrillator implantation: shocks, anxiety, and personality. Health Psychol. 31(2), 186–193 (2012).
   PubMed Web of Science ®Google Scholar
• Pedersen SS, den Broek KC, Theuns DA et al. Risk of chronic anxiety in implantable defibrillator patients: a multi-center study. Int. J. Cardiol. 147(3), 420–423 (2011).
   PubMed Web of Science ®Google Scholar
• Sears SF, Kirian K. Shock and patient-centered outcomes research: is an ICD shock still a critical event? Pacing Clin. Electrophysiol. 33(12), 1437–1441 (2010).
   PubMed Web of Science ®Google Scholar
• Pedersen SS, Versteeg H, Nielsen JC, Mortensen PT, Johansen JB. Patient-reported outcomes in Danish implantable cardioverter defibrillator patients with a Sprint Fidelis lead advisory notification. Europace 13(9), 1292–1298 (2011).
   PubMed Web of Science ®Google Scholar
• Suzuki T, Shiga T, Kuwahara K et al. Prevalence and persistence of depression in patients with implantable cardioverter defibrillator: a 2-year longitudinal study. Pacing Clin. Electrophysiol. 33(12), 1455–1461 (2010).
   PubMed Web of Science ®Google Scholar
• Pedersen SS, Hoogwegt MT, Jordaens L, Theuns DA. Relation of symptomatic heart failure and psychological status to persistent depression in patients with implantable cardioverter-defibrillator. Am. J. Cardiol. 108(1), 69–74 (2011).
   PubMed Web of Science ®Google Scholar
• Pedersen SS, Sears SF, Burg MM, Van Den Broek KC. Does ICD indication affect quality of life and levels of distress? Pacing Clin. Electrophysiol. 32(2), 153–156 (2009).
   PubMed Web of Science ®Google Scholar
• Pedersen SS, Hoogwegt MT, Jordaens L, Theuns DA. Pre implantation psychological functioning preserved in majority of implantable cardioverter defibrillator patients 12 months post implantation. Int. J. Cardiol. doi:10.1016/j.ijcard.2011.10.092 (2011) (Epub ahead of print).
   Google Scholar
• Pedersen SS, Schiffer AA. The distressed (Type D) personality. A risk marker for poor health outcomes in ICD patients. Herzschrittmacherther. Elektrophysiol. 22(3), 181–188 (2011).
   PubMedGoogle Scholar
• Chair SY, Lee CK, Choi KC, Sears SF. Quality of life outcomes in Chinese patients with implantable cardioverter defibrillators. Pacing Clin. Electrophysiol. 34(7), 858–867 (2011).
   PubMed Web of Science ®Google Scholar
• Dunbar SB, Kimble LP, Jenkins LS et al. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress. Anxiety 9(4), 163–168 (1999).
   PubMedGoogle Scholar
• Whang W, Albert CM, Sears SF Jr et al.; TOVA Study Investigators. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J. Am. Coll. Cardiol. 45(7), 1090–1095 (2005).
   PubMed Web of Science ®Google Scholar
• Piotrowicz K, Noyes K, Lyness JM et al. Physical functioning and mental well-being in association with health outcome in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial II. Eur. Heart J. 28(5), 601–607 (2007).
   PubMedGoogle Scholar
• Dougherty CM, Hunziker J. Predictors of implantable cardioverter defibrillator shocks during the first year. J. Cardiovasc. Nurs. 24(1), 21–28; quiz 29 (2009).
   PubMed Web of Science ®Google Scholar
• Shalaby A, Brumberg G, El-Saed A, Saba S. Mood disorders and outcome in patients receiving cardiac resynchronization therapy. Pacing Clin. Electrophysiol. 35(3), 294–301 (2012).
   PubMed Web of Science ®Google Scholar
• Fries R, König J, Schäfers HJ, Böhm M. Triggering effect of physical and mental stress on spontaneous ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators. Clin. Cardiol. 25(10), 474–478 (2002).
   PubMed Web of Science ®Google Scholar
• Lampert R, Joska T, Burg MM, Batsford WP, McPherson CA, Jain D. Emotional and physical precipitants of ventricular arrhythmia. Circulation 106(14), 1800–1805 (2002).
   PubMed Web of Science ®Google Scholar
• Burg MM, Lampert R, Joska T, Batsford W, Jain D. Psychological traits and emotion-triggering of ICD shock-terminated arrhythmias. Psychosom. Med. 66(6), 898–902 (2004).
   PubMed Web of Science ®Google Scholar
• van den Broek KC, Nyklícek I, van der Voort PH, Alings M, Meijer A, Denollet J. Risk of ventricular arrhythmia after implantable defibrillator treatment in anxious type D patients. J. Am. Coll. Cardiol. 54(6), 531–537 (2009).
   PubMed Web of Science ®Google Scholar
• Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom. Med. 67(1), 89–97 (2005).
   PubMed Web of Science ®Google Scholar
• Kao CW, Friedmann E, Thomas SA. Quality of life predicts one-year survival in patients with implantable cardioverter defibrillators. Qual. Life Res. 19(3), 307–315 (2010).
   PubMed Web of Science ®Google Scholar
• Steinberg JS, Joshi S, Schron EB, Powell J, Hallstrom A, McBurnie M; AVID Investigators. Psychosocial status predicts mortality in patients with life-threatening ventricular arrhythmias. Heart Rhythm 5(3), 361–365 (2008).
   PubMed Web of Science ®Google Scholar
• Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study. Arch. Gen. Psychiatry 65(11), 1324–1330 (2008).
   PubMed Web of Science ®Google Scholar
• Pedersen SS, van den Broek KC, Erdman RA, Jordaens L, Theuns DA. Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator. Europace 12(10), 1446–1452 (2010).
   PubMed Web of Science ®Google Scholar
• Tzeis S, Kolb C, Baumert J et al. Effect of depression on mortality in implantable cardioverter defibrillator recipients – findings from the prospective LICAD study. Pacing Clin. Electrophysiol. 34(8), 991–997 (2011).
   PubMed Web of Science ®Google Scholar
• van den Broek KC, Tekle FB, Habibovic M, Alings M, van der Voort PH, Denollet J. Emotional distress, positive affect, and mortality in patients with an implantable cardioverter defibrillator. Int. J. Cardiol. doi:10.1016/j.ijcard.2011.08.071 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• York KM, Hassan M, Sheps DS. Psychobiology of depression/distress in congestive heart failure. Heart Fail. Rev. 14(1), 35–50 (2009).
   PubMed Web of Science ®Google Scholar
• Veith RC, Lewis N, Linares OA et al. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch. Gen. Psychiatry 51(5), 411–422 (1994).
   PubMed Web of Science ®Google Scholar
• Battipaglia I, Barone L, Mariani L et al. Relationship between cardiac autonomic function and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillators. Europace 12(12), 1725–1731 (2010).
   PubMed Web of Science ®Google Scholar
• Francis JL, Weinstein AA, Krantz DS et al. Association between symptoms of depression and anxiety with heart rate variability in patients with implantable cardioverter defibrillators. Psychosom. Med. 71(8), 821–827 (2009).
   PubMed Web of Science ®Google Scholar
• Carney RM, Howells WB, Blumenthal JA et al. Heart rate turbulence, depression, and survival after acute myocardial infarction. Psychosom. Med. 69(1), 4–9 (2007).
   PubMed Web of Science ®Google Scholar
• Sánchez Muñoz JJ, García-Alberola A, Martínez-Sánchez J et al. Premature ventricular complexes as a trigger for ventricular fibrillation. Rev. Esp. Cardiol. 63(7), 798–801 (2010).
   PubMed Web of Science ®Google Scholar
• Barthel P, Schneider R, Bauer A et al. Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation 108(10), 1221–1226 (2003).
   PubMed Web of Science ®Google Scholar
• Whang W, Julien HM, Higginbotham L et al. Women, but not men, have prolonged QT interval if depressed after an acute coronary syndrome. Europace 14(2), 267–271 (2012).
   PubMed Web of Science ®Google Scholar
• Carney RM, Freedland KE, Stein PK et al. Effects of depression on QT interval variability after myocardial infarction. Psychosom. Med. 65(2), 177–180 (2003).
   PubMed Web of Science ®Google Scholar
• Rajamani S, Eckhardt LL, Valdivia CR et al. Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine. Br. J. Pharmacol. 149(5), 481–489 (2006).
   PubMed Web of Science ®Google Scholar
• Gehi AK, Stein RH, Metz LD, Gomes JA. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J. Am. Coll. Cardiol. 46(1), 75–82 (2005).
   PubMed Web of Science ®Google Scholar
• Lampert R, Shusterman V, Burg M et al. Anger-induced T-wave alternans predicts future ventricular arrhythmias in patients with implantable cardioverter-defibrillators. J. Am. Coll. Cardiol. 53(9), 774–778 (2009).
   PubMed Web of Science ®Google Scholar
• Pasic J, Levy WC, Sullivan MD. Cytokines in depression and heart failure. Psychosom. Med. 65(2), 181–193 (2003).
   PubMed Web of Science ®Google Scholar
• Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. J. Clin. Invest. 90(2), 389–398 (1992).
   PubMed Web of Science ®Google Scholar
• Givertz MM, Colucci WS. New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress. Lancet 352(Suppl. 1), SI34–SI38 (1998).
   PubMedGoogle Scholar
• von Känel R, Hepp U, Kraemer B et al. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J. Psychiatr. Res. 41(9), 744–752 (2007).
   PubMed Web of Science ®Google Scholar
• Conraads VM, Denollet J, De Clerck LS, Stevens WJ, Bridts C, Vrints CJ. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure. Int. J. Cardiol. 113(1), 34–38 (2006).
   PubMed Web of Science ®Google Scholar
• Blangy H, Sadoul N, Dousset B et al. Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction. Europace 9(9), 724–729 (2007).
   PubMed Web of Science ®Google Scholar
• Konstantino Y, Kusniec J, Reshef T et al. Inflammatory biomarkers are not predictive of intermediate-term risk of ventricular tachyarrhythmias in stable CHF patients. Clin. Cardiol. 30(8), 408–413 (2007).
   PubMed Web of Science ®Google Scholar
• Geiser F, Meier C, Wegener I et al. Association between anxiety and factors of coagulation and fibrinolysis. Psychother. Psychosom. 77(6), 377–383 (2008).
   PubMed Web of Science ®Google Scholar
• Serrano CV Jr, Setani KT, Sakamoto E, Andrei AM, Fraguas R. Association between depression and development of coronary artery disease: pathophysiologic and diagnostic implications. Vasc. Health Risk Manag. 7, 159–164 (2011).
   PubMedGoogle Scholar
• Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 104(16), 1894–1898 (2001).
   PubMed Web of Science ®Google Scholar
• Joynt KE, Whellan DJ, O’Connor CM. Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J. Card. Fail. 10(3), 258–271 (2004).
   PubMed Web of Science ®Google Scholar
• Gehi A, Haas D, Pipkin S, Whooley MA. Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch. Intern. Med. 165(21), 2508–2513 (2005).
   PubMed Web of Science ®Google Scholar
• Whooley MA, de Jonge P, Vittinghoff E et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 300(20), 2379–2388 (2008).
   PubMed Web of Science ®Google Scholar
• Bunevicius A, Stankus A, Brozaitiene J, Girdler SS, Bunevicius R. Relationship of fatigue and exercise capacity with emotional and physical state in patients with coronary artery disease admitted for rehabilitation program. Am. Heart J. 162(2), 310–316 (2011).
   PubMed Web of Science ®Google Scholar
• van Ittersum M, de Greef M, van Gelder I, Coster J, Brügemann J, van der Schans C. Fear of exercise and health-related quality of life in patients with an implantable cardioverter defibrillator. Int. J. Rehabil. Res. 26(2), 117–122 (2003).
   PubMed Web of Science ®Google Scholar
• Zen AL, Whooley MA, Zhao S, Cohen BE. Post-traumatic stress disorder is associated with poor health behaviors: findings from the Heart and Soul Study. Health Psychol. 31(2), 194–201 (2012).
   PubMed Web of Science ®Google Scholar
• Licinio J, Wong ML. The interface of obesity and depression: risk factors for the metabolic syndrome. Rev. Bras. Psiquiatr. 25(4), 196–197 (2003).
   PubMedGoogle Scholar
• Thorndike AN, Regan S, McKool K et al. Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease. Arch. Intern. Med. 168(2), 186–191 (2008).
   PubMed Web of Science ®Google Scholar
• Tabacco or Health? Physiological and Social Damages Causes by Tobacco Smoking (2nd Edition). Haustein KO, Groneberg D. Springer-Verlag, Berlin Heidelberg, Germany (2010).
   Google Scholar
• McGrady A, McGinnis R, Badenhop D, Bentle M, Rajput M. Effects of depression and anxiety on adherence to cardiac rehabilitation. J. Cardiopulm. Rehabil. Prev. 29(6), 358–364 (2009).
   PubMed Web of Science ®Google Scholar
• DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 160(14), 2101–2107 (2000).
   PubMed Web of Science ®Google Scholar
• Pelle AJ, Schiffer AA, Smith OR, Widdershoven JW, Denollet J. Inadequate consultation behavior modulates the relationship between type D personality and impaired health status in chronic heart failure. Int. J. Cardiol. 142(1), 65–71 (2010).
   PubMed Web of Science ®Google Scholar
• Singh JP, Ellenbogen KA, Desai NR, McAlister FA. ICDs, guidelines, and national registries: opportunities to enhance quality of patient care. Pacing Clin. Electrophysiol. 35(3), 253–258 (2012).
   PubMed Web of Science ®Google Scholar
• Mark DB, Nelson CL, Anstrom KJ et al.; SCD-HeFT Investigators. Cost–effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 114(2), 135–142 (2006).
   PubMed Web of Science ®Google Scholar
• Zwanziger J, Hall WJ, Dick AW et al. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J. Am. Coll. Cardiol. 47(11), 2310–2318 (2006).
   PubMed Web of Science ®Google Scholar
• Braunschweig F, Boriani G, Bauer A et al. Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management. Europace 12(12), 1673–1690 (2010).
   PubMed Web of Science ®Google Scholar
• Pedersen SS, Kupper N, van Domburg RT. Heart and mind: are we closer to disentangling the relationship between emotions and poor prognosis in heart disease? Eur. Heart J. 32(19), 2341–2343 (2011).
   PubMed Web of Science ®Google Scholar
• The Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. National Academy Press, DC, USA (2001).
   Google Scholar
• Salmoirago-Blotcher E, Ockene IS. Methodological limitations of psychosocial interventions in patients with an implantable cardioverter-defibrillator (ICD) A systematic review. BMC Cardiovasc. Disord. 9, 56 (2009).
   PubMedGoogle Scholar
• Donahue RG, Lampert R, Dornelas E, Clemow L, Burg MM; RISTA Investigators. Rationale and design of a randomized clinical trial comparing stress reduction treatment to usual cardiac care: the Reducing Vulnerability to Implantable Cardioverter Defibrillator Shock-Treated Ventricular Arrhythmias (RISTA) trial. Psychosom. Med. 72(2), 172–177 (2010).
   PubMed Web of Science ®Google Scholar
• Pedersen SS, Spek V, Theuns DA et al. Rationale and design of WEBCARE: a randomized, controlled, web-based behavioral intervention trial in cardioverter-defibrillator patients to reduce anxiety and device concerns and enhance quality of life. Trials 10, 120 (2009).
   PubMedGoogle Scholar